Alcon Reports 6% Sales Growth Guidance, Highlights New IOL Technologies
1 report, 1 independent
Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
During its third quarter 2026 earnings call on November 11, 2026, Alcon announced full-year sales growth guidance of approximately 6% and double-digit core earnings-per-share growth. The company noted that new intraocular lenses, including Vivity Pro and TruPlus, are being launched to defend market share in premium cataract surgery. Alcon also expanded the placement of its UNITY VCS surgical console in domestic ophthalmology training centers.
From fool.com
Why it matters
The adoption of advanced intraocular lenses drives high-margin growth for Alcon. Furthermore, placing the UNITY VCS in academic medical centers creates long-term customer lock-in as surgeons become familiar with the system.
From fool.com
Who's involved
- AlconMedical company reporting Q3 2026 earnings and strategic guidance.